Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 37 entries
View as:

Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00815607 Org: User:
Start: 04/30/09 End: 01/31/13 Due: 01/31/14

Phase I Study in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00591292 Org: User:
Start: 06/30/07 End: 06/30/13 Due: 06/30/14

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

Phase: N/A Priority: Normal
NCT ID: NCT02026271 Org: User:
Start: 06/30/15 End: 08/31/19 Due: 08/31/20

Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs

Phase: N/A Priority: Normal
NCT ID: NCT05292859 Org: User:
Start: 10/01/22 End: 06/30/39 Due: 06/30/40

Phase I Study of Indibulin in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00591136 Org: User:
Start: 04/30/03 End: 09/30/08 Due: 09/30/09

A Phase I Trial of ZIO-101 in Hematologic Cancers

Phase: N/A Priority: Normal
NCT ID: NCT00592046 Org: User:
Start: 05/31/05 End: 06/30/08 Due: 06/30/09

Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01113970 Org: User:
Start: 03/31/10 End: 05/31/13 Due: 05/31/14

Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00726687 Org: User:
Start: 06/30/08 End: 06/30/13 Due: 06/30/14

A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00421135 Org: User:
Start: 02/28/06 End: 10/31/07 Due: 10/31/08

Study of ZIO-201 in Advanced Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00439686 Org: User:
Start: 02/28/06 End: 12/31/13 Due: 12/31/14

Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT00591422 Org: User:
Start: 08/31/07 End: 06/30/13 Due: 06/30/14

A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00423306 Org: User:
Start: 01/31/07 End: 12/31/13 Due: 12/31/14

Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans

Phase: N/A Priority: Normal
NCT ID: NCT00591890 Org: User:
Start: 10/31/07 End: 03/31/09 Due: 03/31/10

Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102

Phase: N/A Priority: Normal
NCT ID: NCT03679754 Org: User:
Start: 09/05/18 End: 01/19/21 Due: 01/19/22

Study of ZIO-101 in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00303199 Org: User:
Start: 01/31/06 End: 08/31/07 Due: 08/31/08

A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG

Phase: N/A Priority: Normal
NCT ID: NCT03330197 Org: User:
Start: 09/26/17 End: 09/10/21 Due: 09/10/22

A Phase I Trial of ZIO-101 in Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00591396 Org: User:
Start: 07/31/05 End: 07/31/08 Due: 07/31/09

Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00608803 Org: User:
Start: 01/31/08 End: 01/31/09 Due: 01/31/10

Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01242072 Org: User:
Start: 11/30/10 End: 12/31/12 Due: 12/31/13

Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01139359 Org: User:
Start: 06/30/10 End: 06/30/11 Due: 06/30/12

Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers

Phase: N/A Priority: Normal
NCT ID: NCT00421213 Org: User:
Start: 12/31/06 End: 04/30/12 Due: 04/30/13

Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00591383 Org: User:
Start: 01/31/08 End: 06/30/13 Due: 06/30/14

A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102

Phase: N/A Priority: Normal
NCT ID: NCT03636477 Org: User:
Start: 06/18/18 End: 06/30/21 Due: 06/30/22

Study of Oral Darinaparsin in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01139346 Org: User:
Start: 06/30/10 End: 04/30/12 Due: 04/30/13

Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)

Phase: N/A Priority: Normal
NCT ID: NCT01555710 Org: User:
Start: 05/31/12 End: 06/30/15 Due: 06/30/16